Google AI ModeJun 16, 2026
Cognigenics : Working on RNA-based therapeutics for mood disorders and cognitive impairment.
Cognigenics is a biotechnology company developing an intranasal RNA interference platform designed to deliver therapeutics directly to the brain. Its technology aims to treat neurological and psychiatric disorders by targeting and modulating specific neural circuits related to memory, mood, and cognition.
AI named Cognigenics in June 2026.
None of these answers cited cognigenics.io. AI leaned on biz4group.com, eithealth.eu, and finance.yahoo.com.
cognigenics.io 0%Other sites 100%
Excerpts where Cognigenics appeared in the AI's answer
Cognigenics : Working on RNA-based therapeutics for mood disorders and cognitive impairment.